<?xml version="1.0" encoding="UTF-8"?>
<results title="virus">
 <result pre="an alarming rate over the past decades. The most recent" exact="human coronavirus" post="known as COVID-19 (SARS-CoV-2) has already spread around the"/>
 <result pre="et al. [54] indicated that, depending on the surface, the" exact="human coronavirus" post="can persist for up to 9Â days and at"/>
 <result pre="influenza virus and has potential against different viruses, such as" exact="human coronavirus" post="or SARS-CoV [98]. This use of nanomaterial for facemasks"/>
 <result pre="activity against several viral infections, including hepatitis, influenza, Zika virus," exact="chikungunya virus" post="and other sexually transmitted viruses. Just recently, Loutfy et"/>
 <result pre="carbon quantum dots (CQDs) combined with boric acid to inhibit" exact="human coronavirus" post="HCoV-229E (Fig.Â 5). In this study, the interaction of"/>
 <result pre="developed 10,333 guide RNAs targeting 10 virus peptides and used" exact="adeno-associated virus" post="(AAV) for the targeted transport of cas13d and guide"/>
 <result pre="Pre-clinical COVID-19 vaccine candidate BIOCAD (Russia) LNPs formulated with recombinant" exact="vesicular stomatitis virus" post="(rVSV) that expresses mRNA from SARS-CoV-2 Pre-clinical COVID-19 vaccine"/>
 <result pre="VriesRDRimmelzwaanGFet al.Matrix-Mâ&quot;¢ adjuvant enhances immunogenicity of both protein- and modified" exact="vaccinia virus" post="Ankara-based influenza vaccines in miceImmunol Res20186622423329594879 193.Novavax. Novavax to"/>
</results>
